Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Response to Letter]
Drug Des Devel Ther
.
2025 Jan 6:19:65-66.
doi: 10.2147/DDDT.S512114.
eCollection 2025.
Authors
Young Sang Lyu
1
,
Hongyup Ahn
2
,
Sangmo Hong
3
,
Cheol-Young Park
4
Affiliations
1
Division of Endocrinology and Metabolism, Department of Internal Medicine, Chosun University Hospital, Gwangju, Republic of Korea.
2
Department of Statistics, Dongguk University, Seoul, Republic of Korea.
3
Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Republic of Korea.
4
Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
PMID:
39803608
PMCID:
PMC11721147
DOI:
10.2147/DDDT.S512114
No abstract available
Publication types
Comment